Understanding AI: the need-to-know terms for pharmaceutical marketers

Its dominance in tech news extends to the pharmaceutical sector, which is by no means immune to the charms of AI, with Novartis, Pfizer, GlaxoSmithKline and AstraZeneca just some of the firms signing deals and forming collaborations in the area.

To date, much of this publicly announced work has been focused on drug development in therapy areas such as diabetes, multiple sclerosis, kidney disease and many others, but the possibilities are endless – especially within pharmaceutical marketing.